Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses
Ryo Shinnakasu, Shuhei Sakakibara, Hiromi Yamamoto, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 12
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
Alexander A. Cohen, Neeltje van Doremalen, Allison J. Greaney, et al.
Science (2022) Vol. 377, Iss. 6606
Open Access | Times Cited: 188
Memory B cells
Takeshi Inoue, Tomohiro Kurosaki
Nature reviews. Immunology (2023) Vol. 24, Iss. 1, pp. 5-17
Closed Access | Times Cited: 94
Cell‐specific targeting of extracellular vesicles through engineering the glycocalyx
Wenyi Zheng, Rui He, Xiuming Liang, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 12
Open Access | Times Cited: 50
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
Romain Rouet, Jake Y. Henry, Matt D. Johansen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccinees
Takeshi Inoue, Ryo Shinnakasu, Kawai Chie, et al.
The Journal of Experimental Medicine (2022) Vol. 220, Iss. 2
Open Access | Times Cited: 31
KLF2 expression in IgG plasma cells at their induction site regulates the migration program
Wataru Ise, Takuya Koike, N. Shimada, et al.
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 5
Closed Access
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting
Blake M. Hauser, Maya Sangesland, Kerri St. Denis, et al.
Cell Reports (2022) Vol. 38, Iss. 12, pp. 110561-110561
Open Access | Times Cited: 25
Glycosylation in SARS-CoV-2 variants: A path to infection and recovery
Arya Aloor, Rajaguru Aradhya, P. Dilip Venugopal, et al.
Biochemical Pharmacology (2022) Vol. 206, pp. 115335-115335
Open Access | Times Cited: 21
Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection
Kylie M. Konrath, Kevin Liaw, Yuanhan Wu, et al.
Cell Reports (2022) Vol. 38, Iss. 5, pp. 110318-110318
Open Access | Times Cited: 19
Memory B cell differentiation from germinal centers
Takeshi Inoue
International Immunology (2023) Vol. 35, Iss. 12, pp. 565-570
Open Access | Times Cited: 7
Development of Glycan-masked SARS-CoV-2 RBD vaccines against SARS-related coronaviruses
Zuxin Liang, Chunhui Li, Xiaohua Gong, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012599-e1012599
Open Access | Times Cited: 1
Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal models
Alexander A. Cohen, Neeltje van Doremalen, Allison J. Greaney, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Neutralizing Antibody Response to Sarbecovirus Is Delayed in Sequential Heterologous Immunization
Huibin Lv, Ray T. Y. So, Qi Wen Teo, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1382-1382
Open Access | Times Cited: 5
A survey of mechanisms underlying current and potential COVID‐19 vaccines
Christian Hebel, Allan Randrup Thomsen
Apmis (2022) Vol. 131, Iss. 2, pp. 37-60
Closed Access | Times Cited: 4
Heterologous Sarbecovirus Receptor Binding Domains as Scaffolds for SARS-CoV-2 Receptor Binding Motif Presentation
Blake M. Hauser, Maya Sangesland, Evan C. Lam, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 2, pp. 553-561
Open Access
Designing strong inducible synthetic promoters in yeasts
Jun Ishii, Masahiro Tominaga, Yoko Shima, et al.
Research Square (Research Square) (2024)
Open Access
Reduced Cross-Protective Potential of Omicron Compared to Ancestral SARS-CoV-2 Spike Vaccines Against Potentially Zoonotic Coronaviruses
Tyler M. Renner, Matthew Stuible, Brian Cass, et al.
Research Square (Research Square) (2024)
Open Access
Glycan masking of NTD loops with a chimeric RBD of the spike protein as a vaccine design strategy against emerging SARS‐CoV‐2 Omicron variants
Hao‐Chan Hung, Boon‐Fatt Tan, Wei‐Shuo Lin, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 9
Open Access
Clonal landscape of autoantibody-secreting plasmablasts in COVID-19 patients
Shuhei Sakakibara, Yu‐Chen Liu, Masakazu Ishikawa, et al.
Life Science Alliance (2024) Vol. 7, Iss. 12, pp. e202402774-e202402774
Open Access
Reduced cross-protective potential of Omicron compared to ancestral SARS-CoV-2 spike vaccines against potentially zoonotic coronaviruses
Tyler M. Renner, Matthew Stuible, Brian Cass, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access
Designing strong inducible synthetic promoters in yeasts
Masahiro Tominaga, Yoko Shima, Kenta Nozaki, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice
Lianlian Bian, Yu Bai, Fan Gao, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization
Blake M. Hauser, Maya Sangesland, Evan C. Lam, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 2
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
Romain Rouet, Jake Y. Henry, Matt D. Johansen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Heterologous sarbecovirus receptor binding domains as scaffolds for SARS-CoV-2 receptor binding motif presentation
Blake M. Hauser, Maya Sangesland, Evan C. Lam, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1 - Next Page

Scroll to top